Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Hommel

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Angewandte Chemie (International Ed. in English)|May 5, 2020
Comprehensive and High-Throughput Exploration of Chemical Space Using Broadband <sup>19</sup> F NMR-Based ScreeningAndreas Lingel, Anna Vulpetti, Tony Reinsperger, et al.
Journal of Medicinal Chemistry|March 25, 2008
"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hitsThomas J Crisman, Andreas Bender, Mariusz Milik, et al.
Journal of Medicinal Chemistry|February 4, 2017
Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease InhibitorsAnna Vulpetti, Stefan Randl, Simon Rüdisser, et al.
Protein Science : a Publication of the Protein Society|August 28, 2010
A lead discovery strategy driven by a comprehensive analysis of proteases in the peptide substrate spaceSai Chetan K Sukuru, Florian Nigsch, Jean Quancard, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.
Nature Communications|September 7, 2023
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1βUlrich Hommel, Konstanze Hurth, Jean-Michel Rondeau, et al.
Journal of Medicinal Chemistry|June 17, 2017
Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in VivoEdwige Lorthiois, Karen Anderson, Anna Vulpetti, et al.
ACS Chemical Biology|January 3, 2023
Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC InteractionJian Ding, Guo Li, Hejun Liu, et al.
Nature Chemical Biology|November 4, 2016
Small-molecule factor D inhibitors targeting the alternative complement pathwayJürgen Maibaum, Sha-Mei Liao, Anna Vulpetti, et al.
Journal of Medicinal Chemistry|May 10, 2024
Ligandability Assessment of IL-1β by Integrated Hit Identification ApproachesAnna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Angewandte Chemie (International Ed. in English)|May 5, 2020
Comprehensive and High-Throughput Exploration of Chemical Space Using Broadband <sup>19</sup> F NMR-Based ScreeningAndreas Lingel, Anna Vulpetti, Tony Reinsperger, et al.
Journal of Medicinal Chemistry|March 25, 2008
"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hitsThomas J Crisman, Andreas Bender, Mariusz Milik, et al.
Journal of Medicinal Chemistry|February 4, 2017
Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease InhibitorsAnna Vulpetti, Stefan Randl, Simon Rüdisser, et al.
Protein Science : a Publication of the Protein Society|August 28, 2010
A lead discovery strategy driven by a comprehensive analysis of proteases in the peptide substrate spaceSai Chetan K Sukuru, Florian Nigsch, Jean Quancard, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.
Nature Communications|September 7, 2023
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1βUlrich Hommel, Konstanze Hurth, Jean-Michel Rondeau, et al.
Journal of Medicinal Chemistry|June 17, 2017
Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in VivoEdwige Lorthiois, Karen Anderson, Anna Vulpetti, et al.
ACS Chemical Biology|January 3, 2023
Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC InteractionJian Ding, Guo Li, Hejun Liu, et al.
Nature Chemical Biology|November 4, 2016
Small-molecule factor D inhibitors targeting the alternative complement pathwayJürgen Maibaum, Sha-Mei Liao, Anna Vulpetti, et al.
Journal of Medicinal Chemistry|May 10, 2024
Ligandability Assessment of IL-1β by Integrated Hit Identification ApproachesAnna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, et al.
Pageof 2